A Multi-Modality Approach to Alleviating Monthly Symptoms Many women experience a range of challenging symptoms throughout their reproductive years. While…
The APP 2025 Conference provided an exceptional platform for advancing pharmacy education. A standout session was proudly hosted by Kaneka…
How Kaneka Ubiquinol™ and Mitochondrial Function can Reduce Migraines Migraines affect 15% of the population,[1] presenting as debilitating headaches often…
VitaFoods 2024 Expo was held in Bangkok. Kaneka Ubiquinol™ APAC attended the Vitafoods Asia 2024 Expo in Bangkok. The event…
In this webinar, David will discuss the body of science that supports the varied roles of Ubiquinol, highlighting its effects…
Complementary Medicines Australia (CMA) Innovation Seminar 2022 Kaneka Corporation attended the Complementary Medicines Australia (CMA) Innovation Seminar titled ‘The New…